Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004
Green Light for Phase 2 Trial of AST-004 in Acute Ischemic Stroke Patients Groton, CT, March 12, 2024 – Astrocyte Pharmaceuticals Inc., a clinical-stage biopharmaceutical